New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Athenex, Inc.
ATNX
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

2M

Drug Manufacturers - Specialty & Generic

0.20USD
0.00 ( 0.00%)
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

566%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

99%

Quote Panel

Shape
Updated December 4, 2024
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap

    2.33M


  • Shares Outstanding

    11.49M


  • Share in Float

    6.50M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    0.2031


  • Average Volume

    263314


  • Beta

    1.345179


  • Range

    0.081-23.8


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.athenex.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.02x

P/S Ratio

-0.20x

P/B Ratio

-6.5

Debt/Equity

-96.3%

Net Margin

$-10.4

EPS

How ATNX compares to sector?

P/E Ratio

Relative Strength

Shape

ATNX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.20

arrow
arrow

N/A

-8.80
vs -9.00

Q4.20

arrow
arrow

N/A

-10.60
vs -5.60

Q1.21

arrow
arrow

N/A

-5.40
vs -4.80

Q2.21

arrow
arrow

N/A

-6.60
vs -8.20

Q3.21

arrow
arrow

N/A

-6.60
vs -8.80

Q4.21

arrow
arrow

N/A

-5.80
vs -10.60

Q1.22

arrow
arrow

N/A

-4.80
vs -5.40

Q2.22

arrow
arrow

N/A

-4.60
vs -6.60

Q3.22

arrow
arrow

N/A

-2.80
vs -6.60

Q4.22

arrow
arrow

N/A

-3.38
vs -5.80

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.20

arrow
arrow

+83%

35.5M  vs 19.4M

Q4.20

arrow
arrow

-37%

21.8M  vs 34.4M

Q1.21

arrow
arrow

-13%

41M  vs 46.9M

Q2.21

arrow
arrow

-45%

21.9M  vs 40.2M

Q3.21

arrow
arrow

-9%

32.3M  vs 35.5M

Q4.21

arrow
arrow

+14%

24.9M  vs 21.8M

Q1.22

arrow
arrow

-28%

29.7M  vs 41M

Q2.22

arrow
arrow

+44%

31.5M  vs 21.9M

Q3.22

arrow
arrow

+4%

33.5M  vs 32.3M

Q4.22

arrow
arrow

+1%

25.1M  vs 24.9M

Return on EquityShape

status-upQoQ

Q1.21

arrow
arrow

-16%

-0.16
vs -0.28

Q2.21

arrow
arrow

-19%

-0.19
vs -0.16

Q3.21

arrow
arrow

-24%

-0.24
vs -0.19

Q4.21

arrow
arrow

-190%

-1.90
vs -0.24

Q1.22

arrow
arrow

-80%

-0.80
vs -1.90

Q2.22

arrow
arrow

-201%

-2.01
vs -0.80

Q3.22

arrow
arrow

-79%

-0.79
vs -2.01

Q4.22

arrow
arrow

+442%

4.42
vs -0.79

Institutionnal OwnershipShape

status-upQoQ

Q2.21

arrow
arrow

116

116
vs 132

-12%

Q3.21

arrow
arrow

117

117
vs 116

1%

Q4.21

arrow
arrow

104

104
vs 117

-11%

Q1.22

arrow
arrow

88

88
vs 104

-15%

Q2.22

arrow
arrow

67

67
vs 88

-24%

Q3.22

arrow
arrow

66

66
vs 67

-1%

Q4.22

arrow
arrow

47

47
vs 66

-29%

Q1.23

arrow
arrow

1

1
vs 47

-98%

Earnings Growth

Latest News